PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-06-10

Date Title Company
10-Jun-2024 Integrated DNA Technologies Announces New Primers and Probe Set to Identify H5N1 Avian Influenza Integrated DNA Technologies
10-Jun-2024 Preterm Birth Diagnostic Test Kit Market Continues Upward Trajectory, Projected to Reach to USD 316.5 Million by 2034 at a 7.6% of CAGR MARKITWIRED
10-Jun-2024 Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference AccessWire
10-Jun-2024 KindlyMD(TM) Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah AccessWire
10-Jun-2024 Contraceptives Market Poised for Steady Growth, Reaching US$33.79 Billion by 2034 at a 5.5% CAGR | FMI Study MARKITWIRED
10-Jun-2024 Animal Artificial Insemination Market to Reach US$3.91 Billion by 2033, Driven by 6.0% CAGR and Genetic Enhancement Potential MARKITWIRED
10-Jun-2024 Galimedix Therapeutics Establishes Scientific Advisory Board of Renowned Retina Experts as Company Prepares to Enter Phase 2 Clinical Study with GAL-101 AccessWire
10-Jun-2024 Corneal Ulcer Treatment Market Set for Steady Growth at 5.7% CAGR, Reaching US$1.27 Billion by 2029 | FMI Analysis MARKITWIRED
10-Jun-2024 Sleep Apnea Implants Market Booming at 13.8% CAGR, Poised to Reach US$1.2 Billion by 2033 | FMI Study MARKITWIRED
10-Jun-2024 CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S CS MEDICA
10-Jun-2024 Tharimmune Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis AccessWire
10-Jun-2024 Medical X-Ray Detectors Market Charges Ahead at 5.7% CAGR, Reaching US$3.2 Billion by 2029 | FMI Study MARKITWIRED
10-Jun-2024 Lacrimal Devices Market Expected to Reach US$39.7 Million by 2029 at a 5.5% CAGR | FMI Study MARKITWIRED
10-Jun-2024 Radiation Toxicity Treatment Market Set to Surge at 5.8% CAGR, Reaching US$5.58 Billion by 2029 | FMI Analysis MARKITWIRED
10-Jun-2024 Implantable Drug-Eluting Devices Market Poised for 6.0% CAGR, Reaching US$ 19.3 Billion by 2029 | FMI Study MARKITWIRED
10-Jun-2024 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis Boehringer Ingelheim
10-Jun-2024 Ruvidar(TM) Enhances Efficacy of Cancer Drug AccessWire
10-Jun-2024 Unlock the Future of Cell Analysis with Celledoniaâ„¢ Cytomos
10-Jun-2024 Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19 AccessWire
10-Jun-2024 Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024 AccessWire